Proportion of the target population who received in Europe and Northern America
Europe and Northern America: Proportion of the target population who received was 90.0% in 2024. ▲ Rising
Proportion of the target population who received in Europe and Northern America, 2000–2024
Source: United Nations Statistics Division, SDG Global Database. Measured in %.
Analysis
In 2024, proportion of the target population who received in Europe and Northern America stood at 90.0%.
The figure is down 1.1% on the previous year and up 1.1% over ten years.
Over the whole period, proportion of the target population who received in Europe and Northern America peaked at 92.0% in 2018 and was at its lowest, 60.0%, in 2000.
Europe and Northern America ranks 6th of 37 groups on this measure, in the top quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Proportion of the target population who received in Europe and Northern America, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 60.0% | — |
| 2001 | 62.0% | +3.3% |
| 2002 | 69.0% | +11.3% |
| 2003 | 70.0% | +1.4% |
| 2004 | 73.0% | +4.3% |
| 2005 | 74.0% | +1.4% |
| 2006 | 75.0% | +1.4% |
| 2007 | 76.0% | +1.3% |
| 2008 | 76.0% | +0.0% |
| 2009 | 75.0% | -1.3% |
| 2010 | 79.0% | +5.3% |
| 2011 | 80.0% | +1.3% |
| 2012 | 84.0% | +5.0% |
| 2013 | 88.0% | +4.8% |
| 2014 | 89.0% | +1.1% |
| 2015 | 89.0% | +0.0% |
| 2016 | 89.0% | +0.0% |
| 2017 | 91.0% | +2.2% |
| 2018 | 92.0% | +1.1% |
| 2019 | 92.0% | +0.0% |
| 2020 | 92.0% | +0.0% |
| 2021 | 92.0% | +0.0% |
| 2022 | 91.0% | -1.1% |
| 2023 | 91.0% | +0.0% |
| 2024 | 90.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 71.0% | 60.0% | 76.0% | 10 |
| 2010s | 87.3% | 79.0% | 92.0% | 10 |
| 2020s | 91.2% | 90.0% | 92.0% | 5 |
More infrastructure data for Europe and Northern America
- Proportion of children moderately or severely stunted 3.8% (2024)
- Proportion of children moderately or severely overweight 8.6% (2024)
- Proportion of the target population who received 3 doses of 93.0% (2024)
- Developing countries’ and least developed countries’ share of global 50.9% (2024)
- Developing countries’ and least developed countries’ share of global 47.0% (2024)
- Developing countries’ and least developed countries’ share of global 58.8% (2024)
- Developing countries’ and least developed countries’ share of global 63.5% (2024)
- Proportion of population practicing open defecation, by urban/rural 0.0% (2024)
- Total reserves in months of imports 5.05 ratio (2024)
- Proportion of local breeds classified as being at risk of extinction 83.0% (2025)
Frequently asked questions
- What is proportion of the target population who received in Europe and Northern America?
- Proportion of the target population who received in Europe and Northern America was 90.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest proportion of the target population who received recorded in Europe and Northern America?
- The highest recorded value was 92.0% in 2018.
- What is the lowest proportion of the target population who received recorded in Europe and Northern America?
- The lowest recorded value was 60.0% in 2000.
- How does Europe and Northern America rank for proportion of the target population who received?
- Europe and Northern America ranks 6th out of 37 groups with data for 2024.
- Is proportion of the target population who received rising or falling in Europe and Northern America?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is rising.
- Where does this Europe and Northern America data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under UN SDG Global Database (open, attribution requested).